876322-73-5Relevant academic research and scientific papers
A Putative Single-Photon Emission CT Imaging Tracer for Erythropoietin-Producing Hepatocellular A2 Receptor
Arimitsu, Kenji,Furukawa, Takenori,Kawashima, Hidekazu,Kimura, Hiroyuki,Torimoto, Hanae,Yagi, Yusuke,Yasui, Hiroyuki
supporting information, p. 1238 - 1244 (2021/08/01)
Erythropoietin-producing hepatocellular (Eph) receptors are receptor tyrosine kinases involved in cell-cell contact. The EphA2 receptor is associated with cancer proliferation and migration. Therefore, EphA2 receptor imaging has the potential for cancer d
Method for synthesizing 4- amino -2- trifluoromethyl cyanobenzene
-
Paragraph 0023; 0025; 0027, (2020/03/16)
The method 4 - comprises the following steps, dissolving m-aminotrifluorotoluene in a solvent :S1, and adding ethyl formate, into toluene, and adding acetic acid, to reflux to obtain 4 - amino-2-trifluoromethylbenzonitrile ;S2, and adding the 4 - amino - 2 2-trifluoromethyl cyanobenzaldehyde, into toluene through reflux reaction, to obtain 4 - amino - 2 2-trifluoromethyl cyanobenzonitrile in a ratio. The invention discloses S1 amino- 2 2-trifluoromethyl cyanobenzonitrile in the following processing step: Step 1:1-10, The reaction is mild and no special equipment 8%-10%, is required to be used, 50%-60%. The method comprises the following steps of: synthesizing ethyl formate and refluxing acetic acid; and synthesizing ethyl formate by adding the methyl formate to toluene and refluxing the acetic acid ethyl ester to prepare, amino. 2 2-trifluoromethylbenzonitrile.
Highly chemoselective intermolecular cross-benzoin reactions using an: Ad hoc designed novel N-heterocyclic carbene catalyst
Delany, Eoghan G.,Connon, Stephen J.
supporting information, p. 780 - 786 (2018/02/09)
The design of a novel N-heterocyclic carbene catalyst incorporating a bulky yet highly electron-deficient N-aryl substituent has allowed the development of an efficient protocol for the first highly chemoselective intermolecular benzoin condensations between two non-identical aromatic aldehydes.
PROCESSES FOR MAKING PONATINIB AND INTERMEDIATES THEREOF
-
, (2016/12/26)
Methods are disclosed for making 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-l-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide, intermediates and pharmaceutically acceptable salts thereof.
Syntheses of a triad of Flt3 kinase inhibitors: From bench to pilot plant
Shieh, Wen-Chung,Mckenna, Joe,Sclafani, Joseph A.,Xue, Song,Girgis, Michael,Vivelo, James,Radetich, Branko,Prasad, Kapa
, p. 1146 - 1155 (2013/01/03)
We have designed and developed an alternative synthesis for the manufacturing of a triad of Flt3 kinase inhibitors (AST487, ATH686, and AUZ454) to support clinical assessments of patients with Flt3-dependent tumor diseases. The new synthesis is convergent
Trifluoromethyl substituted benzamides as kinase inhibitors
-
Page/Page column 30, (2008/06/13)
The invention relates to trifluoromethyl substituted benzamide compounds of the formula I, pharmaceuticals comprising these compounds, their use as or for the manufacture of pharmaceuticals, particularly as inhibitors of protein kinases, especially of ephrin receptor kinases, and/or the treatment of a condition, disorder or disease state mediated by a protein kinase activity and/or a proliferative disease, methods of treatment comprising administering the compounds, especially of therapeutic and prophylactic treatment, methods for the manufacture of the compounds and novel intermediates and partial steps for their synthesis.
